Al-Azhar Assiut Medical Journal

ORIGINAL ARTICLE
Year
: 2017  |  Volume : 15  |  Issue : 1  |  Page : 15--20

Transcatheter closure of atrial septal defect in children using the Occlutech Figulla occluder device


Mahmoud Ali1, Amal El-Sisi2, Hesham Salah El-Din1, Sameh Bakhoum1, Hossam Kandil1 
1 Department of Cardiology, Kasr Al Ainy Faculty of Medicine, Cairo University, Cairo, Egypt
2 Department of Pediatric Cardiology, Kasr Al Ainy Faculty of Medicine, Cairo University, Cairo, Egypt

Correspondence Address:
Mahmoud Ali
Department of Cardiology, Kasr Al Ainy Faculty of Medicine, Cairo University, Kasr Al Ainy Street, PO Box 11562, Cairo
Egypt

Background Percutaneous transcatheter closure of atrial septal defect (ASD) among children using devices other than the Amplatzer septal occluder has not been extensively tested. Objectives We evaluated the efficiency and safety of secundum ASD closure using the Occlutech Figulla ASD occluder in children and the efficiency and safety of secundum ASD closure under transthoracic echocardiography (TTE) guidance in children with less than 12 kg body weight. Patients and methods Forty-two patients (19 girls and 23 boys; mean age 4.8±2.0 years) were enrolled in a prospective cohort study. All patients underwent TTE and transesophageal echocardiography (TEE) to assess the characteristics of the ASD before transcatheter closure. Procedures were performed under fluoroscopic and TTE or TEE guidance. Follow-up was done at 1, 3, and 6 months following the procedure by clinical and TTE examination. Results The mean defect size was 14.9±4.2 mm on TTE and 16.1±4.7 mm on TEE. The mean device size was 17.9±4.9 mm (range 10.5–27 mm). The mean procedure time was 59.6±19.5 min. Thirty-one cases were performed under general anesthesia and TEE guidance, whereas the other 11 cases were performed under general anesthesia and TTE guidance. The device was placed successfully in all 42 patients. A small residual flow was seen immediately after device placement in three (7.1%) patients, which disappeared at 6 months. No complications occurred during the procedure. All patients were asymptomatic during the follow-up period. Conclusion Transcatheter closure of secundum ASD is generally safe and efficient in children younger than 12 years old, and ASD closure under TTE guidance in children less than 12 kg body weight is considered safe and efficient when performed in a tertiary center in the presence of an expert echocardiographer and interventional cardiologist.


How to cite this article:
Ali M, El-Sisi A, El-Din HS, Bakhoum S, Kandil H. Transcatheter closure of atrial septal defect in children using the Occlutech Figulla occluder device.Al-Azhar Assiut Med J 2017;15:15-20


How to cite this URL:
Ali M, El-Sisi A, El-Din HS, Bakhoum S, Kandil H. Transcatheter closure of atrial septal defect in children using the Occlutech Figulla occluder device. Al-Azhar Assiut Med J [serial online] 2017 [cited 2017 Nov 18 ];15:15-20
Available from: http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2017;volume=15;issue=1;spage=15;epage=20;aulast=Ali;type=0